Antony Mattessich
Direktor/Vorstandsmitglied bei AURA BIOSCIENCES, INC.
Vermögen: 987 076 $ am 30.04.2024
Aktive Positionen von Antony Mattessich
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AURA BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 29.09.2021 | - |
| Independent Dir/Board Member | 29.09.2021 | - |
Karriereverlauf von Antony Mattessich
Ehemalige bekannte Positionen von Antony Mattessich
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| OCULAR THERAPEUTIX, INC. | Direktor/Vorstandsmitglied | 01.06.2017 | 15.04.2024 |
| Vorstandsvorsitzender | 01.08.2017 | 15.04.2024 | |
| Präsident | 26.07.2017 | 15.04.2024 | |
Mundipharma International Ltd.
 Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | 01.08.2017 | 18.12.2017 |
| Vorstandsvorsitzender | 01.08.2017 | 18.12.2017 | |
| Corporate Officer/Principal | 01.01.2009 | 01.08.2017 | |
| Präsident | 01.08.2017 | 18.12.2017 | |
Napp Pharmaceutical Holdings Ltd.
 Napp Pharmaceutical Holdings Ltd. Pharmaceuticals: MajorHealth Technology Napp Pharmaceutical Holdings Ltd. develops and provides medicines to patients. It offers prescription products for respiratory diseases such as asthma, inflammatory conditions, Crohn's disease, ulcerative colitis, ankylosing spondylitis, rheumatoid arthritis and psoriasis, as well as pain management, blood cancers, and cardiovascular conditions. The company was founded on December 19, 1997 and is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | 01.01.2005 | 01.05.2011 |
| Vorstandsvorsitzender | 01.01.2005 | 01.05.2011 | |
| NOVARTIS AG | Corporate Officer/Principal | 01.01.2003 | 01.01.2005 |
| BRISTOL-MYERS SQUIBB COMPANY | Direktor/Vorstandsmitglied | - | - |
Ausbildung von Antony Mattessich
| The Trustees of Columbia University in The City of New York | Graduate Degree |
| University of California, Berkeley | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| Vereinigtes Königreich | 3 |
| Schweiz | 2 |
Operativ
| Director/Board Member | 5 |
| Chief Executive Officer | 3 |
| Corporate Officer/Principal | 2 |
Sektoral
| Health Technology | 7 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| OCULAR THERAPEUTIX, INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| AURA BIOSCIENCES, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Napp Pharmaceutical Holdings Ltd.
Napp Pharmaceutical Holdings Ltd. Pharmaceuticals: MajorHealth Technology Napp Pharmaceutical Holdings Ltd. develops and provides medicines to patients. It offers prescription products for respiratory diseases such as asthma, inflammatory conditions, Crohn's disease, ulcerative colitis, ankylosing spondylitis, rheumatoid arthritis and psoriasis, as well as pain management, blood cancers, and cardiovascular conditions. The company was founded on December 19, 1997 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Mundipharma International Ltd.
Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Antony Mattessich
- Erfahrung
